Company intelligence / Profile preview
LEO Pharma
Ballerup, Denmarkleopharmamedinfo.com ↗
- Ownership
- Private
- Employees
- ~5000
- Development stage
- Commercial
01
Overview
LEO Pharma has a robust pipeline focused on innovative treatments for skin diseases. Its lead assets include tralokinumab (an anti–IL‑13 mAb for atopic dermatitis) and delgocitinib (a topical pan-JAK inhibitor for chronic hand eczema). The company also develops new biologics and small molecules targeting key inflammatory pathways in dermatology. Several products are approved or in late-stage trials.
- Therapeutic areas
- ImmunologyDermatology
- Modalities
- Topical therapiessmall moleculesmonoclonal antibodies (mAbs)oral tabletsinjectable biologics
- Industry
- Biotech
02
Drug pipeline
52 assets51 more assets in the full pipeline.
Request access →03
Partnerships
Collaborations with academic institutions and industry partners to advance dermatological research; specific partners not detailed in provided results but referenced generally.
Beyond the preview
Go deeper on LEO Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LEO Pharma.